BCL2 and acute myeloid leukemia: It has been demonstrated that BCL-2 inhibitor combined with homoharringtonine markedly inhibits the expression of p-FLT3 and its downstream signaling proteins, p-Stat5 and MCL-1, inducing apoptosis in AML cell lines [19, 49].